ストックスクリーナーアプリを入手
3.90
0.78%
0.03
アフターアワーズ：
3.89
-0.010
-0.26%
前日終値:
$3.87
開ける：
$3.85
24時間の取引高:
961.60K
Relative Volume:
0.72
時価総額：
$333.80M
収益：
-
当期純損益:
$-36.95M
株価収益率:
-4.6429
EPS:
-0.84
ネットキャッシュフロー:
$-33.46M
1週間 パフォーマンス:
+3.45%
1か月 パフォーマンス:
+0.52%
6か月 パフォーマンス:
+33.56%
1年 パフォーマンス:
-51.61%
1日の値動き範囲:
$3.8008
$3.965
1週間の範囲:
$3.6601
$4.045
52週間の値動き範囲:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
名前
Larimar Therapeutics Inc
セクター
電話
844-511-9056
住所
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
LRMR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.90 | 331.23M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-29 | 開始されました | Truist | Buy |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-10-03 | 開始されました | Wedbush | Outperform |
| 2024-10-02 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-03 | 開始されました | Leerink Partners | Outperform |
| 2023-11-17 | アップグレード | Citigroup | Neutral → Buy |
| 2022-10-19 | 開始されました | Guggenheim | Buy |
| 2022-02-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-02-01 | 開始されました | William Blair | Outperform |
すべてを表示
Larimar Therapeutics Inc (LRMR) 最新ニュース
Combining price and volume data for Larimar Therapeutics Inc.July 2025 PreEarnings & Real-Time Volume Surge Alerts - Newser
What’s the recovery path for long term holders of Larimar Therapeutics Inc.Share Buyback & Stock Portfolio Risk Management - Newser
Visual trend scoring systems applied to Larimar Therapeutics Inc.Risk Management & High Conviction Trade Alerts - Newser
Published on: 2025-08-27 04:16:26 - Newser
Why Larimar Therapeutics Inc. is moving todayFree Fundamental Growth Stock Analysis - Newser
Larimar Therapeutics Inc. stock trend outlook and recovery pathQuarterly Profit Review & Community Driven Trade Alerts - Newser
Applying sector rotation models to Larimar Therapeutics Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - Newser
Analyzing net buyer seller activity in Larimar Therapeutics Inc.Bond Market & Daily Technical Forecast Reports - Newser
What technical models suggest about Larimar Therapeutics Inc.’s comebackJuly 2025 Momentum & Accurate Trade Setup Notifications - Newser
Applying Wyckoff theory to Larimar Therapeutics Inc. stockEarnings Growth Summary & Weekly High Conviction Ideas - Newser
Real Time Chart Alerts Flash Bullish on Larimar Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Momentum divergence signals in Larimar Therapeutics Inc. chartCPI Data & Long-Term Growth Plans - Newser
Published on: 2025-08-26 13:11:39 - Newser
Applying big data sentiment scoring on Larimar Therapeutics Inc.Weekly Trade Summary & AI Enhanced Trading Signals - Newser
Published on: 2025-08-26 12:33:38 - Newser
Larimar Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Reactions & High Conviction Investment Ideas - Newser
Published on: 2025-08-26 09:34:00 - Newser
Measuring Larimar Therapeutics Inc.’s beta against major indicesWeekly Trend Summary & Expert Verified Stock Movement Alerts - Newser
Larimar Therapeutics Advances Nomlabofusp Program Toward 2026 FDA Filing - MSN
Is Larimar Therapeutics Inc. stock bottoming outAnalyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Published on: 2025-08-24 14:38:58 - Newser
What to do if you’re stuck in Larimar Therapeutics Inc.2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - Newser
Can Larimar Therapeutics Inc. expand its profit marginsWeekly Investment Recap & Safe Investment Capital Preservation Plans - theviewers.co.kr
Setup Watch: What is Larimar Therapeutics Inc. s debt to equity ratioEarnings Growth Summary & AI Driven Stock Reports - theviewers.co.kr
Should you wait for a breakout in Larimar Therapeutics Inc.Weekly Investment Summary & Community Consensus Stock Picks - Newser
Will Larimar Therapeutics Inc. benefit from rising consumer demandChart Signals & Low Drawdown Trading Strategies - theviewers.co.kr
AI Tools Suggest Larimar Therapeutics Inc. May Outperform This Week2025 Pullback Review & Community Verified Trade Alerts - 더경남뉴스
Citizens JMP Reiterates Buy on Larimar Therapeutics with $18 Price Target - AInvest
Is it time to cut losses on Larimar Therapeutics Inc.Recession Risk & Accurate Buy Signal Notifications - Newser
Larimar Therapeutics (LRMR) Gets a Buy from Citizens JMP - The Globe and Mail
JMP Securities Lowers Larimar Therapeutics (NASDAQ:LRMR) Price Target to $18.00 - MarketBeat
What recovery options are there for Larimar Therapeutics Inc.2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
Exit strategy if you’re trapped in Larimar Therapeutics Inc.Dollar Strength & Fast Gain Stock Trading Tips - Newser
Is Larimar Therapeutics Inc. stock overhyped or has real potential2025 Performance Recap & Comprehensive Market Scan Insights - Newser
Strategies to average down on Larimar Therapeutics Inc.2025 Trading Recap & Real-Time Chart Breakout Alerts - Newser
What are Larimar Therapeutics Inc.’s recent SEC filings showingStop Loss & Fast Gain Stock Tips - sundaytimes.kr
Multi asset correlation models including Larimar Therapeutics Inc.2025 Major Catalysts & Smart Money Movement Alerts - Newser
Using R and stats models for Larimar Therapeutics Inc. forecastingJuly 2025 Summary & Scalable Portfolio Growth Methods - Newser
Larimar Therapeutics Advances Nomlabofusp Program Amid Financial Losses - The Globe and Mail
Larimar Therapeutics reports Q2 EPS (41c), consensus (49c) - MSN
JMP Securities Lowers Price Target for Larimar Therapeutics (LRMR) | LRMR Stock News - GuruFocus
RSI Crosses Above 30 for Larimar Therapeutics Inc. — Reversal in SightJuly 2025 Macro Moves & High Accuracy Buy Signal Tips - 선데이타임즈
Top Analysts Pick 3 Stocks with 300% Upside Potential - AInvest
Larimar Therapeutics Reports Q2 2025 Financial Results - The Globe and Mail
Larimar Therapeutics stock price target lowered to $18 at JMP By Investing.com - Investing.com Canada
Promising Advancements and Strategic Positioning Drive Buy Rating for Larimar Therapeutics - TipRanks
Larimar Therapeutics Inc (LRMR) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):